DE69223939D1 - Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren - Google Patents

Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Info

Publication number
DE69223939D1
DE69223939D1 DE69223939T DE69223939T DE69223939D1 DE 69223939 D1 DE69223939 D1 DE 69223939D1 DE 69223939 T DE69223939 T DE 69223939T DE 69223939 T DE69223939 T DE 69223939T DE 69223939 D1 DE69223939 D1 DE 69223939D1
Authority
DE
Germany
Prior art keywords
cpv
protein
related viruses
vaccine against
fplv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69223939T
Other languages
English (en)
Other versions
DE69223939T2 (de
Inventor
Valdes Elena Cortes
Olmo Carmen Vela
Alvarez Jose Casal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Application granted granted Critical
Publication of DE69223939D1 publication Critical patent/DE69223939D1/de
Publication of DE69223939T2 publication Critical patent/DE69223939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69223939T 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren Expired - Lifetime DE69223939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100844A ES2026826A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
PCT/ES1992/000031 WO1992017205A1 (es) 1991-03-26 1992-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados

Publications (2)

Publication Number Publication Date
DE69223939D1 true DE69223939D1 (de) 1998-02-12
DE69223939T2 DE69223939T2 (de) 1998-07-09

Family

ID=8271929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69223939T Expired - Lifetime DE69223939T2 (de) 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Country Status (8)

Country Link
US (1) US5882652A (de)
EP (1) EP0554414B1 (de)
AT (1) ATE161729T1 (de)
AU (1) AU1585092A (de)
DE (1) DE69223939T2 (de)
DK (1) DK0554414T3 (de)
ES (1) ES2026826A6 (de)
WO (1) WO1992017205A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113572A1 (en) * 1991-07-17 1993-02-04 Peter J. Walker Improved vaccine
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
DK0647655T3 (da) * 1993-01-23 1999-08-23 Inmunologia & Genetica Aplic Syntetiske peptider og vacciner mod parvovirus
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
DK0914440T3 (da) * 1996-04-19 2007-05-21 Merial Ltd Nukleinsyrevaccination mod parvovirusinfektioner
US7556805B2 (en) 1996-12-10 2009-07-07 Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center Compositions for treatment of melanoma and method of using same
EP0959893A4 (de) * 1996-12-10 2004-11-10 Sloan Kettering Institutefor C Stimulierung einer immunantwort auf ein differentiationsantigen, das durch ein verändertes antigen stimuliert wird
EP0863151A1 (de) * 1997-02-12 1998-09-09 Akzo Nobel N.V. Hundeparvovirus DNA Impfstoffe
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US8021666B2 (en) 1997-02-18 2011-09-20 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
ES2340230T3 (es) * 1998-11-10 2010-05-31 University Of North Carolina At Chapel Hill Vectores viricos y sus procedimientos de preparacion y administracion.
CA2373110A1 (en) * 2000-03-14 2001-09-20 Neurologix, Inc. Production of chimeric capsid vectors
AU2005316476A1 (en) * 2004-12-15 2006-06-22 University Of Florida Research Foundation, Inc. Chimeric vectors
EP1981548A4 (de) * 2006-01-20 2010-03-24 Univ North Carolina Verstärkte produktion von infektiösen parvovirus-vektoren in insektenzellen
NZ582019A (en) * 2007-06-14 2012-07-27 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US8647637B2 (en) * 2009-01-30 2014-02-11 The Board Of Regents For Oklahoma State University Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
WO2010093784A2 (en) 2009-02-11 2010-08-19 The University Of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
CA2777692A1 (en) 2009-10-14 2011-04-21 Sanjay Kapil Isolation of a virus related to canine parvovirus-2 from a raccoon
WO2011088081A1 (en) 2010-01-12 2011-07-21 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
EP4234571A3 (de) 2011-02-10 2023-09-27 The University of North Carolina at Chapel Hill Virale vektoren mit modifizierten transduktionsprofilen sowie verfahren zu ihrer herstellung und verwendung
AU2013323270B2 (en) 2012-09-28 2017-09-28 The University Of North Carolina At Chapel Hill AAV vectors targeted to oligodendrocytes
CN105163764B (zh) 2013-03-15 2019-11-12 北卡罗来纳-查佩尔山大学 双重聚糖结合aav载体的方法和组合物
EP2970966A4 (de) 2013-03-15 2016-10-26 Univ North Carolina Synthetische adenoassoziierte virusinvertierte endwiederholungssequenzen
CN104388394B (zh) * 2014-10-22 2017-03-15 中国农业科学院特产研究所 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途
CN114480440A (zh) 2014-11-21 2022-05-13 北卡罗来纳-查佩尔山大学 靶向中枢神经系统的aav载体
US10907176B2 (en) 2015-01-14 2021-02-02 The University Of North Carolina At Chapel Hill Methods and compositions for targeted gene transfer
WO2016127057A1 (en) 2015-02-06 2016-08-11 The University Of North Carolina At Chapel Hill Optimized human clotting factor viii gene expression cassettes and their use
IL292830B2 (en) 2015-09-28 2023-06-01 Univ Florida Methods and compositions for stealth virus antibody vectors
WO2017190031A1 (en) 2016-04-28 2017-11-02 Indiana University Research And Technology Corporation Methods and compositions for resolving components of a virus preparation
AU2018234695A1 (en) 2017-03-15 2019-09-12 The University Of North Carolina At Chapel Hill Polyploid adeno-associated virus vectors and methods of making and using the same
US11668719B2 (en) 2017-09-20 2023-06-06 The Trustees Of Indiana University Methods for resolving lipoproteins with mass spectrometry
CN107827958B (zh) * 2017-11-11 2020-08-25 中牧实业股份有限公司 犬细小病毒合成肽疫苗及其制备方法和应用
EP3738137A1 (de) 2018-01-12 2020-11-18 The Trustees of Indiana University Konstruktion einer elektrostatischen linearen ionenfalle für massenspektrometrie mit ladungsdetektion
SG11202009452WA (en) 2018-04-03 2020-10-29 Stridebio Inc Antibody-evading virus vectors
CN112533644A (zh) 2018-04-03 2021-03-19 斯特里迪比奥公司 靶向眼组织的病毒载体
BR112020020195A2 (pt) 2018-04-03 2021-01-19 Stridebio, Inc. Vetores de vírus com evasão de anticorpos
WO2019236142A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Ion trap array for high throughput charge detection mass spectrometry
EP3803952A1 (de) 2018-06-04 2021-04-14 The Trustees of Indiana University Vorrichtung und verfahren zum einfangen von ionen in einer elektrostatischen linearen ionenfalle
WO2019236143A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Apparatus and method for calibrating or resetting a charge detector
AU2019281714B2 (en) 2018-06-04 2024-05-02 The Trustees Of Indiana University Charge detection mass spectrometry with real time analysis and signal optimization
WO2019236139A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Interface for transporting ions from an atmospheric pressure environment to a low pressure environment
CA3118267A1 (en) 2018-11-20 2020-05-28 The Trustees Of Indiana University Orbitrap for single particle mass spectrometry
AU2019392058A1 (en) 2018-12-03 2021-05-27 The Trustees Of Indiana University Apparatus and method for simultaneously analyzing multiple ions with an electrostatic linear ion trap
AR118465A1 (es) 2019-03-21 2021-10-06 Stridebio Inc Vectores de virus adenoasociados recombinantes
US11942317B2 (en) 2019-04-23 2024-03-26 The Trustees Of Indiana University Identification of sample subspecies based on particle mass and charge over a range of sample temperatures
EP4169535A1 (de) 2019-04-26 2023-04-26 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für dualen glycanbindenden aav2,5-vektor
TW202128736A (zh) 2019-10-17 2021-08-01 美商史崔德生物公司 用於治療ｃ型尼曼—匹克病之腺相關病毒載體
EP4010356B1 (de) 2020-10-28 2024-09-04 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für dualen glycanbindenden aav2.5-vektor
WO2022093769A1 (en) 2020-10-28 2022-05-05 The University Of North Carolina At Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
CN112553168B (zh) * 2020-12-23 2022-03-08 江苏省农业科学院 分泌抗猫细小病毒vp2蛋白单克隆抗体的杂交瘤细胞3a6株及其应用
TW202242124A (zh) 2021-01-14 2022-11-01 美商史崔德生物公司 靶向ｔ細胞之ａａｖ載體
US20240189447A1 (en) 2021-04-16 2024-06-13 Asklepios Biopharmaceutical, Inc. Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
TW202342759A (zh) 2022-02-04 2023-11-01 美商史崔德生物公司 重組腺相關病毒載體及其使用方法
WO2024124019A2 (en) 2022-12-07 2024-06-13 Ginkgo Bioworks, Inc. Aav vectors targeting hematopoietic stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
EP0322417A1 (de) * 1986-09-08 1989-07-05 Applied Biotechnology, Inc. Leere virus kapsidvakzine
US4870023A (en) * 1987-03-16 1989-09-26 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
IL92298A (en) * 1988-11-14 2001-04-30 Us Secretary U S Dept Of Comme Method for producing isolated empty b19 parvovirus capsids, introducing genes into cells utilizing the same, diagnostic assays for detecting parvovirus infection and an anti-parvovirus vaccine containing said capsids
DK0647655T3 (da) * 1993-01-23 1999-08-23 Inmunologia & Genetica Aplic Syntetiske peptider og vacciner mod parvovirus

Also Published As

Publication number Publication date
EP0554414B1 (de) 1998-01-07
DE69223939T2 (de) 1998-07-09
ATE161729T1 (de) 1998-01-15
AU1585092A (en) 1992-11-02
WO1992017205A1 (es) 1992-10-15
US5882652A (en) 1999-03-16
EP0554414A1 (de) 1993-08-11
ES2026826A6 (es) 1992-05-01
DK0554414T3 (da) 1998-09-07

Similar Documents

Publication Publication Date Title
DE69223939D1 (de) Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren
DE69222840D1 (de) Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus
KR920703831A (ko) 백신(vaccines)
JP6346143B2 (ja) 組換え弱毒化パルボウイルス
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
NO871313L (no) Fremgangsmaate for fremstilling av virusvaksine.
Xu et al. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection
RU2001101426A (ru) Аттенуированные вирусы с минус-цепью с измененной антагонистической в отношении интерферона активностью для применения в качестве вакцин и фармацевтических веществ
DE69536138D1 (de) Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
JP7472019B2 (ja) 狂犬病ウイルスワクチン
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
Fahey et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
JP2009544303A5 (de)
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
Vakharia Development of recombinant vaccines against infectious bursal disease
Sheppard Viral vectors for veterinary vaccines
CA2366056A1 (en) Non-spreading pestivirus
ES2650622T3 (es) Vacunas que contienen variantes genéticas de parvovirus canino
Ghafari et al. Cloning and secretory expression of VP2 gene of infectious bursal disease virus in eukaryotic cells
CA2351010A1 (en) A broad spectrum infectious bursal disease virus vaccine
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
Pastoret et al. Regulatory considerations for emergency use of vaccines in the European Union
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
JP2012139193A (ja) 融合タンパク質

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 554414

Country of ref document: EP